Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-07

Clinical Trial Update: Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether Somatuline Autogel 120 mg affects postoperative drainage after total mesorectal excision for rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Somatuline Autogel (lanreotide)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Rectal Carcinoma | Phase 3 | Status: COMPLETED